Aclaris Therapeutics to Participate in the Virtual SVB Securities Global Biopharma Conference

Rhea-AI Summary

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical company, will participate in a fireside chat during the Virtual SVB Securities Global Biopharma Conference on February 14, 2023, at 9:20 AM ET. The event can be accessed via a webcast on the company’s website, where it will be archived for 30 days. Aclaris focuses on developing innovative drug candidates for immuno-inflammatory diseases, aiming to meet the needs of patients with limited treatment options. The company features a strong R&D pipeline exploring protein kinase regulation.

WAYNE, Pa., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the Virtual SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023 at 9:20 AM ET.

A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Therapeutics Contact:

Robert A. Doody Jr.
Vice President, Investor Relations
484-639-7235
rdoody@aclaristx.com

FAQ

What is Aclaris Therapeutics' participation in the Virtual SVB Securities Global Biopharma Conference?

Aclaris Therapeutics will participate in a fireside chat at the Virtual SVB Securities Global Biopharma Conference on February 14, 2023, at 9:20 AM ET.

How can I access the Aclaris Therapeutics fireside chat?

The Aclaris Therapeutics fireside chat can be accessed through a webcast on the 'Events' page of their website, and it will be archived for 30 days.

What is the focus of Aclaris Therapeutics?

Aclaris Therapeutics specializes in developing novel drug candidates for immuno-inflammatory diseases, targeting patients who lack effective treatment options.

What date is the Virtual SVB Securities Global Biopharma Conference?

The Virtual SVB Securities Global Biopharma Conference will take place on February 14, 2023.